Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Replimune Group, Raises Price Target to $50 By Benzinga Newsdesk February 10, 1:09 PM HC Wainwright & Co. analyst Robert Burns reiterates Replimune Group (NASDAQ:REPL) with a Buy and raises the price target from $48 to $50. REPL
Read More 2 minute read Analyst Color Analyst Ratings Markets News Reiteration Tech Trading Ideas Why These Analysts Believe YELP Can Succeed Against Negative Macroeconomic Winds By Natan Ponieman February 10, 1:08 PM Online review aggregator Yelp Inc (NYSE:YELP) released fourth-quarter earnings on Thursday, with very strong results that beat Street estimates. YELP
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $5 Price Target By Benzinga Newsdesk February 10, 1:06 PM HC Wainwright & Co. analyst Yi Chen reiterates Applied DNA Sciences (NASDAQ:APDN) with a Buy and maintains $5 price target. APDN
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $16 Price Target By Benzinga Newsdesk February 10, 1:04 PM HC Wainwright & Co. analyst Yi Chen reiterates Sensus Healthcare (NASDAQ:SRTS) with a Buy and maintains $16 price target. SRTS
Read More 1 minute read Analyst Ratings News Price Target Reiteration Mizuho Reiterates Buy on WEX, Maintains $200 Price Target By Benzinga Newsdesk February 10, 8:59 AM Mizuho analyst Dan Dolev reiterates WEX (NYSE:WEX) with a Buy and maintains $200 price target. WEX
Read More 1 minute read Analyst Ratings News Price Target Reiteration Mizuho Reiterates Buy on PayPal Holdings, Maintains $100 Price Target By Benzinga Newsdesk February 10, 8:57 AM Mizuho analyst Dan Dolev reiterates PayPal Holdings (NASDAQ:PYPL) with a Buy and maintains $100 price target. PYPL
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $21 Price Target By Benzinga Newsdesk February 10, 8:53 AM HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price target. NVCT
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Coursera, Maintains $19 Price Target By Benzinga Newsdesk February 10, 7:57 AM Needham analyst Ryan MacDonald reiterates Coursera (NYSE:COUR) with a Buy and maintains $19 price target. COUR
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Orion Energy Sys, Maintains $7 Price Target By Benzinga Newsdesk February 10, 7:11 AM HC Wainwright & Co. analyst Amit Dayal reiterates Orion Energy Sys (NASDAQ:OESX) with a Buy and maintains $7 price target. OESX
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Engagesmart, Maintains $40 Price Target By Benzinga Newsdesk February 10, 7:06 AM Needham analyst Scott Berg reiterates Engagesmart (NYSE:ESMT) with a Buy and maintains $40 price target. ESMT